Nicholas Keen is CSO at BICYCLE THERAPEUTICS PLC (BCYC). They have made 13 open-market trades across 1 company since 2021, most recently 2024-07-03.
CIK 0001776881
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCYC | 62,024 | $230K |
Shares reported on the most recent Form 4, priced at the 2024-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCYC | SELL | 2024-07-03 | 2024-07-08 | $19.64 | $15K | +12.5% | +12.4% | +16.7% |
| BCYC | SELL | 2024-04-03 | 2024-04-05 | $23.81 | $19K | -4.0% | +2.5% | -11.1% |
| BCYC | SELL | 2024-01-03 | 2024-01-04 | $17.50 | $46K | +7.4% | +0.2% | +37.5% |
| BCYC | SELL | 2023-10-03 | 2023-10-05 | $20.00 | $5K | -8.8% | -30.7% | -18.2% |
| BCYC | SELL | 2023-07-03 | 2023-07-06 | $25.10 | $8K | +2.1% | -5.4% | -18.4% |
| BCYC | SELL | 2023-04-03 | 2023-04-05 | $21.11 | $7K | -7.5% | +2.8% | +16.9% |
| BCYC | SELL | 2023-01-03 | 2023-01-05 | $29.06 | $106K | -10.9% | -8.4% | -31.3% |
| BCYC | SELL | 2021-10-01 | 2021-10-05 | $45.08 | $250K | +29.5% | +24.4% | +29.9% |
| BCYC | SELL | 2021-09-15 | 2021-09-17 | $45.01 | $311K | -8.8% | +33.6% | +25.0% |
| BCYC | SELL | 2021-09-02 | 2021-09-03 | $40.00 | $400K | +10.6% | +10.3% | +43.9% |
| BCYC | SELL | 2021-07-14 | 2021-07-16 | $35.00 | $350K | -3.8% | -16.7% | +75.5% |
| BCYC | SELL | 2021-03-31 | 2021-04-02 | $30.00 | $300K | -1.7% | +5.1% | +1.8% |
| BCYC | SELL | 2021-03-12 | 2021-03-16 | $28.48 | $285K | -3.4% | +9.6% | +8.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.